Prince R A, Pincheira J C, Mason E E, Printen K J
J Clin Pharmacol. 1984 Nov-Dec;24(11-12):523-7. doi: 10.1002/j.1552-4604.1984.tb02762.x.
Seven adult, morbidly obese patients scheduled for bariatric surgery were studied in an identical manner preoperatively and postoperatively. Six patients underwent gastroplasties, and one patient underwent a gastric bypass procedure. A single 250-mg dose of erythromycin as a Filmtab was administered orally after an overnight fast. Multiple venous blood samples were collected over a 12-hour period. After surgery, each patient had a decrease in peak concentration and an increase in the time to reach peak concentration compared to presurgery values. Mean peak concentration was reduced from 1.04 micrograms/ml preoperatively to 0.55 micrograms/ml postoperatively, and the mean time to peak increased from 3.9 hours to 6.7 hours. Mean weight-corrected AUC was reduced 41 per cent, with two patients having no detectable serum levels postoperatively. The results suggest that the erythromycin product evaluated is of questionable value for use in bariatric surgery patients.
对7名计划接受减肥手术的成年病态肥胖患者在术前和术后采用相同方式进行了研究。6名患者接受了胃成形术,1名患者接受了胃旁路手术。在禁食过夜后,口服单剂量250毫克的红霉素薄膜片。在12小时内采集多份静脉血样。术后,与术前值相比,每位患者的峰值浓度均降低,达到峰值浓度的时间增加。平均峰值浓度从术前的1.04微克/毫升降至术后的0.55微克/毫升,平均达峰时间从3.9小时增加到6.7小时。平均体重校正后的曲线下面积降低了41%,两名患者术后血清中检测不到药物水平。结果表明,所评估的红霉素产品在减肥手术患者中的使用价值存疑。